June 18, 2009 / 5:19 AM / 10 years ago

US approves Novartis auto-inflammatory drug

ZURICH, June 18 (Reuters) - U.S. regulators have approved Novartis AG’s NOVN.VX Ilaris to treat children and adults with a serious life long auto-inflammatory disease, the Swiss drugmaker said on Thursday.

It is the first approved treatment for patients as young as four who suffer from two forms of cryopyrin-associated periodic syndrome (CAPS), whose symptoms can include debilitating fatigue, rash, fever, headaches, joint pain and conjunctivitis, Novartis said in a statement. (Reporting by Sam Cage)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below